TSSC4
U5 small nuclear ribonucleoprotein TSSC4
Also known as: TSSC4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y5U2
- Gene
- TSSC4
- Ensembl
- ENSG00000184281
- Chromosome
- 11
- Canonical length
- 329 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene is one of several tumor-suppressing subtransferable fragments located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian, and breast cancer. This gene is located among several imprinted genes; however, this gene, as well as the pan-hematopoietic expression gene (PHEMX), escapes imprinting. This gene may play a role in malignancies and disease that involve this region. Several transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]
Canonical amino-acid sequenceUniProt
329 residues, UniProt reviewed canonical sequence.
>Q9Y5U2|TSSC4
1 MAEAGTGEPS PSVEGEHGTE YDTLPSDTVS LSDSDSDLSL PGGAEVEALS PMGLPGEEDS
61 GPDEPPSPPS GLLPATVQPF HLRGMSSTFS QRSRDIFDCL EGAARRAPSS VAHTSMSDNG
121 GFKRPLAPSG RSPVEGLGRA HRSPASPRVP PVPDYVAHPE RWTKYSLEDV TEVSEQSNQA
181 TALAFLGSQS LAAPTDCVSS FNQDPSSCGE GRVIFTKPVR GVEARHERKR VLGKVGEPGR
241 GGLGNPATDR GEGPVELAHL AGPGSPEAEE WGSHHGGLQE VEALSGSVHS GSVPGLPPVE
301 TVGFHGSRKR SRDHFRNKSS SPEDPGAEVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TSSC4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.69
- Highest tissue expression
- 70 nTPM
Expression across tissuesHPA
Tissue
- testis: 70 nTPM
- skeletal muscle: 62 nTPM
- liver: 49 nTPM
- colon: 43 nTPM
- endometrium: 42 nTPM
- bone marrow: 40 nTPM
Single-cell type
- late spermatids: 295 nCPM
- late primary spermatocytes: 210 nCPM
- syncytiotrophoblasts: 95 nCPM
- esophageal suprabasal cells: 92 nCPM
- esophageal apical cells: 91 nCPM
- early primary spermatocytes: 84 nCPM
Immune cell
- basophil: 106 nTPM
- naive B-cell: 88 nTPM
- T-reg: 75 nTPM
- NK-cell: 71 nTPM
- eosinophil: 70 nTPM
- MAIT T-cell: 69 nTPM
Brain region
- thalamus: 32 nTPM
- white matter: 32 nTPM
- medulla oblongata: 30 nTPM
- basal ganglia: 30 nTPM
- midbrain: 30 nTPM
- cerebellum: 29 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.72
- gnomAD pLI
- 0.04
- gnomAD missense Z
- -0.65
- DepMap mean gene effect
- 0.14
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Tumour suppressing sub-chromosomal transferable candidate 4
- Tumour suppressing sub-chromosomal transferable candidate 4
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TSSC4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TSSC4 as an antibody target. Whether an autoantibody or antibody against TSSC4 could matter depends on whether native TSSC4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TSSC4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TSSC4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...